Paul Rutherford Carter Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul Rutherford Carter.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul Rutherford Carter. Paul Rutherford Carter is a EVP Commercial Ops in GILEAD SCIENCES INC ($GILD) and a Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and a Director in Mallinckrodt plc ($MNK).
Address: 2 ROUNDWOOD AVENUE SOUTH BUILDING STOCKLEY PARK UXBRIDGE, MIDDLESEX UB11 1AFUnited Kingdom
Companies in which Paul Rutherford Carter is an Insider
ALDER BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul Rutherford Carter: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 24 2019
$ALDR Market Capitalization: $1.19B
$ALDR Previous Close: $23.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GILEAD SCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Paul Rutherford Carter: EVP Commercial Ops
Holdings: 64,122 shares
Current Value: $4,689,242
Latest Transaction: Aug 03 2016
$GILD Market Capitalization: $88.05B
$GILD Previous Close: $73.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mallinckrodt plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul Rutherford Carter: Director
Holdings: 10,041 shares
Current Value: $508,878
Latest Transaction: May 17 2019
$MNK Market Capitalization: $5.32B
$MNK Previous Close: $50.68
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Paul Rutherford Carter
Sentiment: All, ALDR, GILD, MNK
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 11.01 | 22,500 | 247,725 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 15.50 | 15,000 | 232,500 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 16.90 | 15,000 | 253,500 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 29.26 | 15,000 | 438,900 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 31.10 | 30,000 | 933,000 | 0 | |
| May 28 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | A | 11.01 | 22,500 | 247,725 | 22,500 | |
| May 17 2019 | MNK | Mallinckrodt plc | Carter Paul Rutherford | Director | Grant | A | 0.00 | 19,396 | 0 | 29,437 | 10 K to 29.4 K (+193.17 %) |